Novo Nordisk (NVO)
(Delayed Data from NYSE)
$131.54 USD
+1.55 (1.19%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $131.58 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 1 - 20 ( 196 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for NVO 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department